| Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors B Routy, E Le Chatelier, L Derosa, CPM Duong, MT Alou, R Daillère, ... Science 359 (6371), 91-97, 2018 | 4401 | 2018 |
| Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota M Vétizou, JM Pitt, R Daillère, P Lepage, N Waldschmitt, C Flament, ... Science 350 (6264), 1079-1084, 2015 | 3085 | 2015 |
| Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells LB John, C Devaud, CPM Duong, CS Yong, PA Beavis, NM Haynes, ... Clinical cancer research 19 (20), 5636-5646, 2013 | 773 | 2013 |
| Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects R Daillère, M Vétizou, N Waldschmitt, T Yamazaki, C Isnard, ... Immunity 45 (4), 931-943, 2016 | 753 | 2016 |
| Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade MC Andrews, CPM Duong, V Gopalakrishnan, V Iebba, WS Chen, ... Nature medicine 27 (8), 1432-1441, 2021 | 252 | 2021 |
| Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage A Fluckiger, R Daillère, M Sassi, BS Sixt, P Liu, F Loos, C Richard, ... Science 369 (6506), 936-942, 2020 | 246 | 2020 |
| Gut bacteria composition drives primary resistance to cancer immunotherapy in renal cell carcinoma patients L Derosa, B Routy, M Fidelle, V Iebba, L Alla, E Pasolli, N Segata, ... European urology 78 (2), 195-206, 2020 | 228 | 2020 |
| Autoimmunity associated with immunotherapy of cancer SM Amos, CPM Duong, JA Westwood, DS Ritchie, RP Junghans, ... Blood, The Journal of the American Society of Hematology 118 (3), 499-509, 2011 | 221 | 2011 |
| Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade N Jacquelot, T Yamazaki, MP Roberti, CPM Duong, MC Andrews, ... Cell research 29 (10), 846-861, 2019 | 198 | 2019 |
| Predictors of responses to immune checkpoint blockade in advanced melanoma N Jacquelot, MP Roberti, DP Enot, S Rusakiewicz, N Ternès, S Jegou, ... Nature communications 8 (1), 592, 2017 | 189 | 2017 |
| Cancer immunotherapy utilizing gene-modified T cells: from the bench to the clinic CPM Duong, CSM Yong, MH Kershaw, CY Slaney, PK Darcy Molecular immunology 67 (2), 46-57, 2015 | 140 | 2015 |
| Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer MP Roberti, S Yonekura, CPM Duong, M Picard, G Ferrere, M Tidjani Alou, ... Nature medicine 26 (6), 919-931, 2020 | 138 | 2020 |
| Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy C Devaud, JA Westwood, LB John, JK Flynn, S Paquet-Fifield, ... Molecular Therapy 22 (1), 18-27, 2014 | 133 | 2014 |
| Oncolytic virus and anti–4-1BB combination therapy elicits strong antitumor immunity against established cancer LB John, LJ Howland, JK Flynn, AC West, C Devaud, CP Duong, ... Cancer research 72 (7), 1651-1660, 2012 | 117 | 2012 |
| The angular branch of the thoracodorsal artery and its blood supply to the inferior angle of the scapula: an anatomical study S Seneviratne, C Duong, IG Taylor Plastic and reconstructive surgery 104 (1), 85-88, 1999 | 72 | 1999 |
| Enhancing the specificity of T-cell cultures for adoptive immunotherapy of cancer CPM Duong, JA Westwood, LJ Berry, PK Darcy, MH Kershaw Immunotherapy 3 (1), 33-48, 2011 | 68 | 2011 |
| Targeting chemokines and chemokine receptors in melanoma and other cancers N Jacquelot, CPM Duong, GT Belz, L Zitvogel Frontiers in immunology 9, 416529, 2018 | 67 | 2018 |
| Engineering T cell function using chimeric antigen receptors identified using a DNA library approach CPM Duong, JA Westwood, CSM Yong, A Murphy, C Devaud, LB John, ... PLoS One 8 (5), e63037, 2013 | 65 | 2013 |
| Tumor ablation by gene-modified T cells in the absence of autoimmunity LXJ Wang, JA Westwood, M Moeller, CPM Duong, WZ Wei, J Malaterre, ... Cancer research 70 (23), 9591-9598, 2010 | 58 | 2010 |
| Cancer induces a stress ileopathy depending on β-adrenergic receptors and promoting dysbiosis that contributes to carcinogenesis S Yonekura, S Terrisse, C Alves Costa Silva, A Lafarge, V Iebba, ... Cancer discovery 12 (4), 1128-1151, 2022 | 50 | 2022 |
